Global Docetaxel Market Insights, Forecast to 2025


Report ID : RNR-224344 Category : Pharma Healthcare Published Date : 2018
Publisher : QYResearch Pages : 114 Format : PDF
This report studies the global market size of Docetaxel in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Docetaxel in these regions.

This research report categorizes the global Docetaxel market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

Docetaxel is a chemotherapy medication used to treat a number of types of Cancer. This includes breast Cancer, head and neck Cancer, stomach Cancer, Prostate Cancer and non-small-cell lung Cancer. It may be used by itself or along with other chemotherapy medication. It is given by slow injection into a vein.

The classification of Docetaxel includes 20 mg/ml, 40 mg/ml and 60 mg/ml. And the proportion of 20 mg/ml in 2017 is about 86% and the proportion is stable from 2013 to 2017.

Docetaxel is widely used For Breast Cancer, Prostate Cancer, Non-small Cell Lung Cancer and Cancer. The most proportion of Docetaxel used for Breast Cancer and the proportion in 2017 is 85%.

In 2017, the global Docetaxel market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Docetaxel market based on company, product type, application and key regions.

The various contributors involved in the value chain of Docetaxel include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Docetaxel include

- Hengrui Medicine

- Sanofi

- Qilu Pharma

- Shenzhen Main Luck Pharma

- Jiangsu Aosaikang Pharma

Market Size Split by Type

- 20 mg/ml

- 40 mg/ml

- 60 mg/ml

Market Size Split by Application

- Breast Cancer

- Prostate Cancer

- Non-small Cell Lung Cancer

- Other

Market size split by Region

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Malaysia

- - Philippines

- - Thailand

- - Vietnam

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- Central & South America

- - Brazil

- - Rest of Central & South America

- Middle East & Africa

- - GCC Countries

- - Turkey

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global Docetaxel market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.

- To understand the structure of Docetaxel market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global Docetaxel manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the Docetaxel with respect to individual growth trends, future prospects, and their contribution to the total market.

- To project the value and volume of Docetaxel submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Docetaxel are as follows:

- History Year: 2013-2017

- Base Year: 2017

- Estimated Year: 2018

- Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Docetaxel market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
1.1 Docetaxel Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Docetaxel Market Size Growth Rate by Type
1.4.2 20 mg/ml
1.4.3 40 mg/ml
1.4.4 60 mg/ml
1.5 Market by Application
1.5.1 Global Docetaxel Market Size Growth Rate by Application
1.5.2 Breast Cancer
1.5.3 Prostate Cancer
1.5.4 Non-small Cell Lung Cancer
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Docetaxel Market Size
2.1.1 Global Docetaxel Revenue 2016-2025
2.1.2 Global Docetaxel Sales 2016-2025
2.2 Docetaxel Growth Rate by Regions
2.2.1 Global Docetaxel Sales by Regions
2.2.2 Global Docetaxel Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Docetaxel Sales by Manufacturers
3.1.1 Docetaxel Sales by Manufacturers
3.1.2 Docetaxel Sales Market Share by Manufacturers
3.1.3 Global Docetaxel Market Concentration Ratio (CR5 and HHI)
3.2 Docetaxel Revenue by Manufacturers
3.2.1 Docetaxel Revenue by Manufacturers (2016-2018)
3.2.2 Docetaxel Revenue Share by Manufacturers (2016-2018)
3.3 Docetaxel Price by Manufacturers
3.4 Docetaxel Manufacturing Base Distribution, Product Types
3.4.1 Docetaxel Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Docetaxel Product Category
3.4.3 Date of International Manufacturers Enter into Docetaxel Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
4.1 Global Docetaxel Sales by Type
4.2 Global Docetaxel Revenue by Type
4.3 Docetaxel Price by Type
5 Breakdown Data by Application
5.1 Overview
5.2 Global Docetaxel Breakdown Data by Application
6 North America
6.1 North America Docetaxel by Countries
6.1.1 North America Docetaxel Sales by Countries
6.1.2 North America Docetaxel Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Docetaxel by Type
6.3 North America Docetaxel by Application
6.4 North America Docetaxel by Company
7 Europe
7.1 Europe Docetaxel by Countries
7.1.1 Europe Docetaxel Sales by Countries
7.1.2 Europe Docetaxel Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Docetaxel by Type
7.3 Europe Docetaxel by Application
7.4 Europe Docetaxel by Company
8 Asia Pacific
8.1 Asia Pacific Docetaxel by Countries
8.1.1 Asia Pacific Docetaxel Sales by Countries
8.1.2 Asia Pacific Docetaxel Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Docetaxel by Type
8.3 Asia Pacific Docetaxel by Application
8.4 Asia Pacific Docetaxel by Company
9 Central & South America
9.1 Central & South America Docetaxel by Countries
9.1.1 Central & South America Docetaxel Sales by Countries
9.1.2 Central & South America Docetaxel Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Docetaxel by Type
9.3 Central & South America Docetaxel by Application
9.4 Central & South America Docetaxel by Company
10 Middle East and Africa
10.1 Middle East and Africa Docetaxel by Countries
10.1.1 Middle East and Africa Docetaxel Sales by Countries
10.1.2 Middle East and Africa Docetaxel Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Docetaxel by Type
10.3 Middle East and Africa Docetaxel by Application
10.4 Middle East and Africa Docetaxel by Company
11 Company Profiles
11.1 Hengrui Medicine
11.1.1 Hengrui Medicine Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Docetaxel
11.1.4 Docetaxel Product Description
11.1.5 Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Docetaxel
11.2.4 Docetaxel Product Description
11.2.5 Recent Development
11.3 Qilu Pharma
11.3.1 Qilu Pharma Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Docetaxel
11.3.4 Docetaxel Product Description
11.3.5 Recent Development
11.4 Shenzhen Main Luck Pharma
11.4.1 Shenzhen Main Luck Pharma Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Docetaxel
11.4.4 Docetaxel Product Description
11.4.5 Recent Development
11.5 Jiangsu Aosaikang Pharma
11.5.1 Jiangsu Aosaikang Pharma Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Docetaxel
11.5.4 Docetaxel Product Description
11.5.5 Recent Development
12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators
13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Docetaxel Raw Material
13.1.2 Docetaxel Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer
List of Tables and Figures
Figure Picture of Docetaxel
Figure Global Docetaxel Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Docetaxel Production Market Share by Types (Product Category) in 2017
Figure 20 mg/ml Product Picture
Table Major Manufacturers of 20 mg/ml
Figure 40 mg/ml Product Picture
Table Major Manufacturers of 40 mg/ml
Figure 60 mg/ml Product Picture
Table Major Manufacturers of 60 mg/ml
Table Global Docetaxel Market Size Growth Rate by Application 2018-2025 (K Units)
Figure Breast Cancer
Figure Prostate Cancer
Figure Non-small Cell Lung Cancer
Figure Other
Figure Docetaxel Report Years Considered
Figure Global Docetaxel Market Size 2016-2025 (Million US$)
Figure Global Docetaxel Sales 2016-2025 (K Units)
Table Global Docetaxel Market Size by Regions 2016-2025 (K Units) & (Million US$)
Table Global Docetaxel Sales by Regions 2016-2025 (K Units)
Table Global Docetaxel Sales Market Share by Regions 2016-2025
Figure Global Docetaxel Sales Market Share by Regions 2016-2025
Figure 2017 Global Docetaxel Sales Market Share by Regions
Table Global Docetaxel Revenue by Regions 2016-2025 (Million US$)
Table Global Docetaxel Revenue Market Share by Regions 2016-2025
Figure Global Docetaxel Revenue Market Share by Regions 2016-2025
Figure 2017 Global Docetaxel Revenue Market Share by Regions
Table Global Docetaxel Sales by Manufacturers (2016-2018) (K Units)
Table Global Docetaxel Sales Share by Manufacturers (2016-2018)
Figure Global Docetaxel Sales Share by Manufacturers in 2017
Table Docetaxel Revenue by Manufacturers (2016-2018) (Million US$)
Table Docetaxel Revenue Share by Manufacturers (2016-2018)
Figure Docetaxel Value Share by Manufacturers in 2017
Table Global Docetaxel Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Docetaxel Price (2016-2018) (USD/Unit)
Table Docetaxel Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Docetaxel Product Category
Table Date of International Manufacturers Enter into Docetaxel Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Docetaxel Sales by Type (2016-2025) (K Units)
Table Global Docetaxel Sales Share by Type (2016-2025)
Figure Global Docetaxel Sales Market Share by Type (2016-2025)
Figure Global Docetaxel Sales Market Share by Type in 2017
Table Global Docetaxel Revenue by Type (2016-2025) (Million US$)
Table Global Docetaxel Revenue Share by Type (2016-2025)
Figure Global Docetaxel Revenue Market Share by Type (2016-2025)
Figure Global Docetaxel Revenue Market Share by Type in 2017
Table Docetaxel Price by Type 2013-2018 (USD/Unit)
Table Global Docetaxel Sales by Application (2016-2025) (K Units)
Table Global Docetaxel Sales Share by Application (2016-2025)
Figure Global Sales Docetaxel Market Share by Application (2016-2025)
Figure Global Sales Docetaxel Market Share by Application (2016-2025)
Figure North America Docetaxel Sales Growth Rate 2016-2025 (K Units)
Figure North America Docetaxel Revenue Growth Rate 2016-2025 (Million US$)
Table North America Docetaxel Sales by Countries (2016-2025) (K Units)
Table North America Docetaxel Sales Market Share by Countries (2016-2025)
Figure 2017 North America Docetaxel Sales Market Share by Countries
Table North America Docetaxel Revenue by Countries (2016-2025) (Million US$)
Table North America Docetaxel Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Docetaxel Revenue Market Share by Countries
Figure United States Docetaxel Sales Growth Rate (2016-2025) (K Units)
Figure United States Docetaxel Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Docetaxel Sales Growth Rate (2016-2025) (K Units)
Figure Canada Docetaxel Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Docetaxel Sales Growth Rate (2016-2025) (K Units)
Figure Mexico Docetaxel Revenue Growth Rate (2016-2025) (Million US$)
Table North America Docetaxel Sales by Type (2016-2025) (K Units)
Table North America Docetaxel Sales Market Share by Type (2016-2025)
Figure 2017 North America Docetaxel Market Share by Type
Table North America Docetaxel Sales by Application (2016-2025) (K Units)
Table North America Docetaxel Sales Market Share by Application (2016-2025)
Figure 2017 North America Docetaxel Market Share by Application
Table North America Docetaxel Sales by Company (2016-2018) (K Units)
Table North America Docetaxel Sales Market Share by Company (2016-2018)
Figure North America Docetaxel Sales Market Share by Company in 2017
Figure Europe Docetaxel Sales Growth Rate 2016-2025 (K Units)
Figure Europe Docetaxel Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Docetaxel Sales by Countries (2016-2025) (K Units)
Table Europe Docetaxel Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Docetaxel Sales Market Share by Countries
Table Europe Docetaxel Revenue by Countries (2016-2025) (Million US$)
Table Europe Docetaxel Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Docetaxel Revenue Market Share by Countries
Figure Germany Docetaxel Sales Growth Rate (2016-2025) (K Units)
Figure Germany Docetaxel Revenue Growth Rate (2016-2025) (K Units)
Figure France Docetaxel Sales Growth Rate (2016-2025) (K Units)
Figure France Docetaxel Revenue Growth Rate (2016-2025) (K Units)
Figure UK Docetaxel Sales Growth Rate (2016-2025) (K Units)
Figure UK Docetaxel Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Docetaxel Sales Growth Rate (2016-2025) (K Units)
Figure Italy Docetaxel Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Docetaxel Sales Growth Rate (2016-2025) (K Units)
Figure Russia Docetaxel Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Docetaxel Sales by Type (2016-2025) (K Units)
Table Europe Docetaxel Sales Market Share by Type (2016-2025)
Figure 2017 Europe Docetaxel Market Share by Type
Table Europe Docetaxel Sales by Application (2016-2025) (K Units)
Table Europe Docetaxel Sales Market Share by Application (2016-2025)
Figure 2017 Europe Docetaxel Market Share by Application
Table Europe Docetaxel Sales by Company (2016-2018) (K Units)
Table Europe Docetaxel Sales Market Share by Company (2016-2018)
Figure Europe Docetaxel Sales Market Share by Company in 2017
Figure Asia Pacific Docetaxel Sales Growth Rate 2016-2025 (K Units)
Figure Asia Pacific Docetaxel Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Docetaxel Sales by Countries (2016-2025) (K Units)
Table Asia Pacific Docetaxel Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Docetaxel Sales Market Share by Countries
Table Asia Pacific Docetaxel Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Docetaxel Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Docetaxel Revenue Market Share by Countries
Figure China Docetaxel Sales Growth Rate (2016-2025) (K Units)
Figure China Docetaxel Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Docetaxel Sales Growth Rate (2016-2025) (K Units)
Figure Japan Docetaxel Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Docetaxel Sales Growth Rate (2016-2025) (K Units)
Figure Korea Docetaxel Revenue Growth Rate (2016-2025) (Million US$)
Figure India Docetaxel Sales Growth Rate (2016-2025) (K Units)
Figure India Docetaxel Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Docetaxel Sales Growth Rate (2016-2025) (K Units)
Figure Australia Docetaxel Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Docetaxel Sales Growth Rate (2016-2025) (K Units)
Figure Indonesia Docetaxel Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Docetaxel Sales Growth Rate (2016-2025) (K Units)
Figure Malaysia Docetaxel Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Docetaxel Sales Growth Rate (2016-2025) (K Units)
Figure Philippines Docetaxel Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Docetaxel Sales Growth Rate (2016-2025) (K Units)
Figure Thailand Docetaxel Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Docetaxel Sales Growth Rate (2016-2025) (K Units)
Figure Vietnam Docetaxel Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Docetaxel Sales Growth Rate (2016-2025) (K Units)
Figure Singapore Docetaxel Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Docetaxel Sales by Type (2016-2025) (K Units)
Table Asia Pacific Docetaxel Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Docetaxel Market Share by Type
Table Asia Pacific Docetaxel Sales by Application (2016-2025) (K Units)
Table Asia Pacific Docetaxel Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Docetaxel Market Share by Application
Table Asia Pacific Docetaxel Sales by Company (2016-2018) (K Units)
Table Asia Pacific Docetaxel Sales Market Share by Company (2016-2018)
Figure Asia Pacific Docetaxel Sales Market Share by Company in 2017
Figure Central & South America Docetaxel Sales Growth Rate 2016-2025 (K Units)
Figure Central & South America Docetaxel Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Docetaxel Sales by Countries (2016-2025) (K Units)
Table Central & South America Docetaxel Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Docetaxel Sales Market Share by Countries
Table Central & South America Docetaxel Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Docetaxel Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Docetaxel Revenue Market Share by Countries
Figure Brazil Docetaxel Sales Growth Rate (2016-2025) (K Units)
Figure Brazil Docetaxel Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Docetaxel Sales Growth Rate (2016-2025) (K Units)
Figure Argentina Docetaxel Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Docetaxel Sales by Type (2016-2025) (K Units)
Table Central & South America Docetaxel Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Docetaxel Market Share by Type
Table Central & South America Docetaxel Sales by Application (2016-2025) (K Units)
Table Central & South America Docetaxel Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Docetaxel Market Share by Application
Table Central & South America Docetaxel Sales by Company (2016-2018) (K Units)
Table Central & South America Docetaxel Sales Market Share by Company (2016-2018)
Figure Central & South America Docetaxel Sales Market Share by Company in 2017
Figure Middle East and Africa Docetaxel Sales Growth Rate 2016-2025 (K Units)
Figure Middle East and Africa Docetaxel Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Docetaxel Sales by Countries (2016-2025) (K Units)
Table Middle East and Africa Docetaxel Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Docetaxel Sales Market Share by Countries
Table Middle East and Africa Docetaxel Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Docetaxel Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Docetaxel Revenue Market Share by Countries
Figure GCC Countries Docetaxel Sales Growth Rate (2016-2025) (K Units)
Figure GCC Countries Docetaxel Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Docetaxel Sales Growth Rate (2016-2025) (K Units)
Figure Turkey Docetaxel Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Docetaxel Sales Growth Rate (2016-2025) (K Units)
Figure Egypt Docetaxel Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Docetaxel Sales Growth Rate (2016-2025) (K Units)
Figure South Africa Docetaxel Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Docetaxel Sales by Type (2016-2025) (K Units)
Table Middle East and Africa Docetaxel Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Docetaxel Market Share by Type
Table Middle East and Africa Docetaxel Sales by Application (2016-2025) (K Units)
Table Middle East and Africa Docetaxel Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Docetaxel Market Share by Application
Table Middle East and Africa Docetaxel Sales by Company (2016-2018) (K Units)
Table Middle East and Africa Docetaxel Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Docetaxel Sales Market Share by Company in 2017
Table Hengrui Medicine Company Details
Table Hengrui Medicine Docetaxel Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Hengrui Medicine Recent Development
Table Sanofi Company Details
Table Sanofi Docetaxel Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Sanofi Recent Development
Table Qilu Pharma Company Details
Table Qilu Pharma Docetaxel Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Qilu Pharma Recent Development
Table Shenzhen Main Luck Pharma Company Details
Table Shenzhen Main Luck Pharma Docetaxel Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Shenzhen Main Luck Pharma Recent Development
Table Jiangsu Aosaikang Pharma Company Details
Table Jiangsu Aosaikang Pharma Docetaxel Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Jiangsu Aosaikang Pharma Recent Development
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Docetaxel Value Chain
Table Typical Suppliers of Key Docetaxel Raw Material
Table Docetaxel Customers List
Table Docetaxel Sales Channels
Table Docetaxel Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources